in a groundbreaking offstage discussion, medical professionals have decided to disregard pre-existing conditions in their upcoming experimental treatment trials, allowing a wider array of participants to benefit from advancements in healthcare. this decision, announced just moments ago, marks a vibrant rebeginning for patient inclusivity and research methodologies, promising a more hopeful future for individuals previously marginalized from such medical studies.